Subsequent Events (Details) - Subsequent Events - License Agreement - DRI Healthcare Acquisitions LP $ in Millions |
Oct. 03, 2024
USD ($)
|
|---|---|
| Subsequent Event [Line Items] | |
| Proceeds from Collaborators | $ 57.0 |
| Contingent upfront payment | 50.0 |
| Minimum | |
| Subsequent Event [Line Items] | |
| License fee receivable | 5.0 |
| Maximum | |
| Subsequent Event [Line Items] | |
| License fee receivable | $ 40.0 |
| X | ||||||||||
- Definition Contingent Fee Receivable, Threshold Amount No definition available.
|
| X | ||||||||||
- Definition License Fee Receivable No definition available.
|
| X | ||||||||||
- Definition Cash received from collaborators during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|